SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.306
EU - Europa 5.487
AS - Asia 3.499
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
AF - Africa 2
Totale 33.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.253
CN - Cina 2.045
UA - Ucraina 1.617
IT - Italia 964
DE - Germania 940
TR - Turchia 868
GB - Regno Unito 749
SG - Singapore 433
SE - Svezia 400
FI - Finlandia 360
PL - Polonia 213
BE - Belgio 71
FR - Francia 59
CA - Canada 53
ID - Indonesia 30
CZ - Repubblica Ceca 25
IN - India 25
VN - Vietnam 24
IR - Iran 22
RU - Federazione Russa 19
AT - Austria 16
BR - Brasile 16
JP - Giappone 12
NL - Olanda 12
CO - Colombia 11
KR - Corea 11
HK - Hong Kong 10
RO - Romania 10
CL - Cile 8
EU - Europa 8
AU - Australia 6
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
IE - Irlanda 4
NZ - Nuova Zelanda 4
CH - Svizzera 3
DK - Danimarca 3
GR - Grecia 3
HR - Croazia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
BG - Bulgaria 2
DZ - Algeria 2
IL - Israele 2
IQ - Iraq 2
LU - Lussemburgo 2
NO - Norvegia 2
PK - Pakistan 2
AL - Albania 1
ES - Italia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MC - Monaco 1
MM - Myanmar 1
NP - Nepal 1
PE - Perù 1
TH - Thailandia 1
Totale 33.354
Salva come PNG Salva come JPEG
Città #
Fairfield 3.528
Woodbridge 3.260
Houston 2.097
Jacksonville 1.838
Ashburn 1.687
Ann Arbor 1.681
Chandler 1.534
Seattle 1.397
Wilmington 1.256
Cambridge 1.191
Izmir 544
Nanjing 491
Princeton 405
Beijing 390
Ferrara 367
Boardman 304
San Diego 303
Singapore 248
Warsaw 211
Milan 205
New York 179
Shanghai 168
Shenyang 154
Nanchang 151
Dearborn 146
Falls Church 125
San Mateo 113
Jiaxing 96
Tianjin 87
Addison 84
Hebei 84
Changsha 81
Mountain View 81
Redwood City 77
Bremen 74
Norwalk 72
Brussels 67
Jinan 61
Washington 57
Auburn Hills 51
Los Angeles 51
Zhengzhou 49
Philadelphia 47
Munich 45
Kunming 44
London 43
Montréal 35
Ningbo 35
Tappahannock 34
Guangzhou 32
Helsinki 30
Jakarta 30
Des Moines 29
Mcallen 27
Indiana 25
Verona 24
Bologna 22
Ferrara di Monte Baldo 22
Orange 21
Dong Ket 20
Redmond 18
Lanzhou 17
Taizhou 17
Leawood 16
Brno 15
St Louis 14
Augusta 13
San Francisco 12
Vienna 12
Changchun 11
Ardabil 10
Hefei 10
Prescot 10
Fuzhou 9
Hangzhou 9
Kilburn 9
Padova 9
Toronto 9
Bari 8
Florence 8
Hong Kong 8
Hounslow 8
Walnut 8
Chiswick 7
Haikou 7
Medellín 7
Olomouc 7
Chicago 6
Osasco 6
Turin 6
Yellow Springs 6
Chisinau 5
Düsseldorf 5
Wandsworth 5
Bogotá 4
Catania 4
Dublin 4
Edinburgh 4
Hanoi 4
Islington 4
Totale 25.961
Salva come PNG Salva come JPEG
Nome #
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 196
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 176
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 169
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 164
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 163
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 159
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 157
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 146
Physicochemical stability of cabazitaxel and docetaxel solutions 146
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 144
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 141
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 137
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 137
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 137
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 134
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 134
A new selective antagonist of the nociceptin receptor 133
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 132
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 131
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 131
Pharmacological characterization of nociceptin receptor: an in vitro study 131
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 130
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 130
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 129
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 129
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 129
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 129
Preferential interaction of the Alzheimer peptide Aβ-(1-42) with Omega-3-containing lipid bilayers: Structure and interaction studies 128
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 128
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 127
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 127
A new ligand for the urotensin II receptor 126
Studies of the cardiovascular effects of nociceptin and related peptides 125
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 125
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 125
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 124
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 123
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 123
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 122
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 122
null 121
Cardiovascular effects of nociceptin in unanesthetized mice 120
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 120
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 119
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 119
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 119
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 119
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 118
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 118
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 117
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 116
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 116
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 115
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 115
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 115
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 114
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 114
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 114
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 114
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 113
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 113
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 113
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 113
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 113
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 113
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 112
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 112
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 112
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 111
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 111
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 110
Copper Binding to the Neurotoxic Peptide PrP106-126. Thermodynamic and Structural Studies 110
null 110
Pharmacological characterization of tachykinin tetrabranched derivatives 110
Design of d-opioid peptide antagonists for emerging drug applications 110
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 109
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 108
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 108
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 108
Synthesis and antimicrobial activity of dermaseptin S1 analogues 108
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 108
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 108
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 108
null 107
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 107
Opioid receptor selectivity alteration by single residue replacement: Synthesis and activity profile of [Dmt]deltorphin B 107
Characterization of nociceptin/orphanin FQ binding sites in dog brain membranes 107
Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices 107
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 107
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. 107
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 107
Desensitisation of native and recombinant human urotensin-II receptors. 107
Nociceptin/orphanin FQ prevents ethanol-induced gastric lesions in the rat 107
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 106
Structure-activity study at positions 3 and 4 of human neuropeptide S. 106
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 106
Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux 105
null 105
Totale 12.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.608
Totale 138.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.264 1.173 302 311 1.219 608 991 819 878 690 730 350 193
2020/20215.193 418 485 243 646 226 558 184 616 162 700 649 306
2021/20224.133 164 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.870 418 165 124 474 638 536 195 380 544 21 225 150
2023/20241.918 225 248 114 49 110 296 74 176 41 39 62 484
2024/2025149 149 0 0 0 0 0 0 0 0 0 0 0
Totale 33.858